Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Reactive oxygen species (ROS)-responsive biomaterials mediate tissue microenvironments and tissue regeneration
Y Yao, H Zhang, Z Wang, J Ding, S Wang… - Journal of Materials …, 2019 - pubs.rsc.org
Reactive oxygen species (ROS) have been considered the pivotal signaling molecules in
many physiological processes, and are usually overproduced in various inflammatory …
many physiological processes, and are usually overproduced in various inflammatory …
Nanotechnology for cardiovascular diseases
Q Hu, Z Fang, J Ge, H Li - The Innovation, 2022 - cell.com
Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine …
S Sun, W Lv, S Li, Q Zhang, W He, Z Min, C Teng… - ACS …, 2023 - ACS Publications
Brain inflammation is regarded as one of the leading causes that aggravates secondary
brain injury and hinders the prognosis of ischemic stroke. After ischemic stroke, high …
brain injury and hinders the prognosis of ischemic stroke. After ischemic stroke, high …
Bioresponsive drug delivery systems for the treatment of inflammatory diseases
Y Dou, C Li, L Li, J Guo, J Zhang - Journal of Controlled Release, 2020 - Elsevier
Inflammation is intimately related to the pathogenesis of numerous acute and chronic
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
Nanomaterials for nanotheranostics: tuning their properties according to disease needs
Nanotheranostics is one of the biggest scientific breakthroughs in nanomedicine. Most of the
currently available diagnosis and therapies are invasive, time-consuming, and associated …
currently available diagnosis and therapies are invasive, time-consuming, and associated …
Microthrombus‐targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke
Reperfusion injury exists as the major obstacle to full recovery of neuron functions after
ischemic stroke onset and clinical thrombolytic therapies. Complex cellular cascades …
ischemic stroke onset and clinical thrombolytic therapies. Complex cellular cascades …
Elaborately engineering a self‐Indicating dual‐drug nanoassembly for site‐specific photothermal‐potentiated thrombus penetration and thrombolysis
Z Zhao, X Zhang, H Zhang, X Shan, M Bai… - Advanced …, 2022 - Wiley Online Library
Thrombotic cardio‐cerebrovascular diseases seriously threaten human health. Currently,
conventional thrombolytic treatments are challenged by the low utilization, inferior thrombus …
conventional thrombolytic treatments are challenged by the low utilization, inferior thrombus …
Construction of intelligent moving micro/nanomotors and their applications in biosensing and disease treatment
Y Guo, D **g, S Liu, Q Yuan - Theranostics, 2023 - pmc.ncbi.nlm.nih.gov
Micro/nanomotors are containers that pass through liquid media and carry cargo. Because
they are tiny, micro/nanomotors exhibit excellent potential for biosensing and disease …
they are tiny, micro/nanomotors exhibit excellent potential for biosensing and disease …
Advanced drug delivery system against ischemic stroke
S Zhang, Y Zhou, R Li, Z Chen, X Fan - Journal of Controlled Release, 2022 - Elsevier
Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …
Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy
Thrombosis is a principle cause of various life-threatening cardiovascular diseases.
However, current antithrombotic treatments using drugs only offer limited efficacy due to …
However, current antithrombotic treatments using drugs only offer limited efficacy due to …